Puberty blockers for under-18s with gender dysphoria will be banned indefinitely across the UK except for use in clinical trials, the government has announced.
Wes Streeting, the health secretary, said that after receiving advice from medical experts, he would make existing emergency measures banning the sale and supply of puberty blockers indefinite.
The Department of Health and Social Care said the Commission on Human Medicines (CHM) had published independent expert advice that there was “currently an unacceptable safety risk in the continued prescription of puberty blockers to children”.
Unacceptable safety risk in trans kids feeling comfortable with who they are as human beings.
WTF puberty blockers aren’t used for only trans kids. They are also used to treat precocious puberty.
That’s still legal. Only banned for gender dysmorphia.
That is messed up as heck.
These monsters just hate trans kids so much. TERF island strikes again.
Care to elaborate on the safety risks there, Wes?
A review of the infamous CASS report:
Results from 5 uncontrolled, observational studies suggest that, in children and adolescents with gender dysphoria, gender-affirming hormones are likely to improve symptoms of gender dysphoria, and may also improve depression, anxiety, quality of life, suicidality, and psychosocial functioning. The impact of treatment on body image is unclear. All results were of very low certainty using modified GRADE
Safety outcomes were reported in 5 observational studies. Statistically significant increases in some measures of bone density were seen following treatment with gender-affirming hormones, although results varied by bone region (lumber spine versus femoral neck) and by population (transfemales versus transmales). However, z-scores suggest that bone density remained lower in transfemales and transmales compared with an equivalent cisgender population. Results from 1 study of gender-affirming hormones started during adolescence reported statistically significant increases in blood pressure and body mass index, and worsening of the lipid profile (in transmales) at age 22 years, although longer term studies that report on cardiovascular event rates are required. Adverse events and discontinuation rates associated with gender-affirming hormones were only reported in 1 study, and no conclusions can be made on these outcomes.
This document was prepared in October 2020
Evidence review (.PDF): Gender-affirming hormones for children and adolescents with gender dysphoria https://cass.independent-review.uk/wp-content/uploads/2022/09/20220726_Evidence-review_Gender-affirming-hormones_For-upload_Final.pdf
Other reading:
Fact Check: New York Times Publishes Misleading Story On Puberty Blocker Study
Watching:
Exposing the Dangers of Anti-Trans Fascism | RE: The Cass Review & Labour’s Downfall
That’s not for them to decide, they’re not the experts.
They are acting upon the recommendation of the largest systematic review of the evidence in the UK to date.
The plan is " to set up a clinical trial into the use of puberty blockers next year and to recruit the first patients by spring. Streeting said the study would help “establish a clear evidence base for the use of this medicine”."
Essentially, the research on this has been so polarized, the results so conflicting and the science riddled with terrible methodology etc that the government is saying “fuck it, we’ll establish our own gigantic study.”
Ouch.
evil fucking bastards
Removed by mod
Removed by mod
